EPO Patents = 10

Forward Citations = 1

Loading Chart...

3 inventors (with patents filed for the assignee):

Dirk Lochmann (6 out of 11 patents)

Sebastian Reyer (6 out of 11 patents)

Michael Stehr (6 out of 11 patents)

6 patents: Sort by Forward Citations

1. 12421530 - Method for producing glycerides of hydroxycarboxylic acids (2025-09-23),

2. 12415774 - Polyol-based esters of hydroxycarboxylic acids (2025-09-16),

3. 12365645 - Method for producing fatty alcohol esters of hydroxycarboxylic acids (2025-07-22),

4. 12258609 - Method for producing glycerides of hydroxycarboxylic acids (2025-03-25),

5. 12091383 - Method for producing lipids comprising structural units based on glycerides of hydroxycarboxylc acids (2024-09-17),

6. 11919851 - Method for producing polyol-based esters of optionally acylated hydroxycarboxylic acids (2024-03-05),

Ketolipix Therapeutics GmbH is a biopharmaceutical company focused on developing innovative therapies for metabolic disorders. The company specializes in the research and development of novel lipid-based treatments aimed at addressing conditions such as obesity and diabetes. With a commitment to advancing healthcare through scientific innovation, Ketolipix Therapeutics leverages cutting-edge technology and a team of experienced professionals to bring new solutions to market. Their pipeline includes several promising candidates that are currently in various stages of clinical development, aiming to improve patient outcomes and quality of life.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

6 Patents

#186 in

#5,304 in Germany

DE

Ketolipix Therapeutics Gmbh

Forward Citations = 1

3 inventors:

Dirk Lochmann (6 out of 11 patents)

Sebastian Reyer (6 out of 11 patents)

Michael Stehr (6 out of 11 patents)

Please report any incorrect information to support@idiyas.com

10 patents (EPO):

Please report any incorrect information to support@idiyas.com